CID 16725726

Gsk690693

Structural Information

Molecular Formula
C21H27N7O3
SMILES
CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N
InChI
InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1
InChIKey
KGPGFQWBCSZGEL-ZDUSSCGKSA-N
Compound name
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

66
References

7546
Patents

425.21753 Da
Monoisotopic Mass

0.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 426.22481 199.0
[M+Na]+ 448.20675 206.5
[M-H]- 424.21025 196.0
[M+NH4]+ 443.25135 200.4
[M+K]+ 464.18069 199.4
[M+H-H2O]+ 408.21479 181.0
[M+HCOO]- 470.21573 202.4
[M+CH3COO]- 484.23138 202.6
[M+Na-2H]- 446.19220 195.7
[M]+ 425.21698 192.0
[M]- 425.21808 192.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe